{
    "clinical_study": {
        "@rank": "28386", 
        "arm_group": [
            {
                "arm_group_label": "Group 3", 
                "arm_group_type": "Experimental", 
                "description": "Vitamin D3, 10,000 IU daily"
            }, 
            {
                "arm_group_label": "Group 2", 
                "arm_group_type": "Experimental", 
                "description": "Vitamin D3 2,000 IU daily"
            }, 
            {
                "arm_group_label": "Group 1", 
                "arm_group_type": "Experimental", 
                "description": "Vitamin D3 600 IU daily (Control group, RDA level)"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose for this study is to determine the effect of vitamin D supplementation on\n      disease activity in Crohn's disease patients in Canada and Saudi Arabia"
        }, 
        "brief_title": "The Impact of Vitamin D on Disease Activity in Crohn's Disease", 
        "condition": "Crohn Disease,", 
        "condition_browse": {
            "mesh_term": "Crohn Disease"
        }, 
        "detailed_description": {
            "textblock": "Hypothesis 1: Patients who are suffering from Crohn's disease are at risk of vitamin D\n      deficiency.\n\n      To determine vitamin D status and disease activity in Crohn's disease cases in Canada and\n      Saudi Arabia.\n\n      Hypothesis 2: Providing vitamin D in doses higher than RDA (Recommended Dietary Allowance)\n      reduces disease activity in Crohn's disease cases.\n\n      To evaluate the impact vitamin D in doses higher than RDA (Recommended Dietary Allowance) on\n      disease activity in Crohn's disease patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  newly diagnosis with an active Crohn's disease,\n\n          -  age above of 16 years\n\n        Exclusion Criteria:\n\n          -  remission or the duration of disease is more than 2 years,\n\n          -  pregnancy,\n\n          -  liver or kidney failure,\n\n          -  inability to take oral supplements or medicine"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01864616", 
            "org_study_id": "VCD-060"
        }, 
        "intervention": {
            "arm_group_label": [
                "Group 3", 
                "Group 2", 
                "Group 1"
            ], 
            "intervention_name": "Vitamin D3", 
            "intervention_type": "Dietary Supplement"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Cholecalciferol", 
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Vitamin D", 
            "Crohn disease", 
            "Disease activity", 
            "Inflammation", 
            "prevention"
        ], 
        "lastchanged_date": "May 24, 2013", 
        "link": {
            "description": "investigator: Hassanali Vatanparast", 
            "url": "http://www.usask.ca/pharmacy-nutrition/the-college/faculty-staff_contacts/nutrition_and_dietetics/vatanparast_hassanali.php"
        }, 
        "location": [
            {
                "contact": {
                    "email": "j.jones@usask.ca", 
                    "last_name": "Jennifer Jones, MD,MSc, FRCPC", 
                    "phone": "306-966-6341"
                }, 
                "contact_backup": {
                    "email": "vatan.h@usask.ca", 
                    "last_name": "HassanAli Vatanparast, MD,PhD", 
                    "phone": "306-966-6341"
                }, 
                "facility": {
                    "address": {
                        "city": "Saskatoon", 
                        "country": "Canada", 
                        "state": "Saskatchewan"
                    }, 
                    "name": "IBD clinic; Royal University Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Hassanali Vatanparast, MD,PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Hani Jawa, MBBS,ABIM,FRCPC", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Wael El-matary, MBChB,MSc,MD,FRCPCH", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jennifer Jones, MD,MSc,FRCPC", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Dania A Alrefai, M.Sc", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jawa.hani@gmail.com", 
                    "last_name": "Hani A Jawa, PHD", 
                    "phone": "+96626401000"
                }, 
                "contact_backup": {
                    "email": "dania.alrefai@gmail.com", 
                    "last_name": "Dania Alrefai, M.Sc", 
                    "phone": "+13068814026"
                }, 
                "facility": {
                    "address": {
                        "city": "Jeddah", 
                        "country": "Saudi Arabia"
                    }, 
                    "name": "Internal Medicine Department; King Abdulaziz University Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Hassanali Vatanparast, MD,PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Jennifer Jones, MD,MSc,FRCPC", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Hani Jawa, MBBS,ABIM,FRCPC", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Wael El-matary, MBChB,MSc,MD,FRCPCH", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Dania Alrefai, M.Sc", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Canada", 
                "Saudi Arabia"
            ]
        }, 
        "number_of_arms": "3", 
        "overall_contact": {
            "email": "vatan.h@usask.ca", 
            "last_name": "Hassanali Vatanparast, MD, PhD", 
            "phone": "306-966-6341"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Saskatchewan, Saskatoon, SK,Canada", 
                "last_name": "Hassanali Vatanparast, MD,PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Royal University Hospital, Saskatoon, Saskatchewan, Canada", 
                "last_name": "Jennifer Jones, MD,MSc,FRCPC", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "King Abdulaziz University, jeddah, Saudi Arabia", 
                "last_name": "Hani Jawa, MBBS,ABIM,FRCPC", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "University of Manitoba", 
                "last_name": "Wael El-matary, MBChB,MSc,MD,FRCPCH", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "University of Saskatchewan", 
                "last_name": "Dania Alrefai, M.Sc", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Canada: Ethics Review Committee", 
                "Canada: Health Canada", 
                "Saudi Arabia: Ethics Committee"
            ]
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "We have 4 time points, baseline (0), Week 5, Week 9 (termination) and Week 17 (follow up) To measure the disease activity, we will examine C- reactive protein levels \"blood test\", Fecal fat \" stool test\" and Crohn's disease activity index (CDAI)\"tool\".", 
            "measure": "The changes in disease activity on groups", 
            "safety_issue": "No", 
            "time_frame": "(0), 5 weeks, 9 weeks, after 2 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01864616"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Saskatchewan", 
            "investigator_full_name": "Hassanali Vatanparast", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "We have 4 time points, baseline (0), Week 5, Week 9 (termination) and Week 17 (follow up). We will use 24-hour dietary recalls for 9 different days.", 
                "measure": "nutritional status", 
                "safety_issue": "No", 
                "time_frame": "0, 5 weeks, 9 weeks, 2 months later"
            }, 
            {
                "description": "We have 4 time points, baseline (0), Week 5, Week 9 (termination) and Week 17 (follow up) vitamin D status: Blood test", 
                "measure": "vitamin D status", 
                "safety_issue": "No", 
                "time_frame": "(0), Week 5, Week 9 (termination) and 2 months later"
            }, 
            {
                "description": "We have 4 time points, baseline (0), Week 5, Week 9 (termination) and Week 17 (follow up). We will use Health related quality of life questionnaire.", 
                "measure": "Health related quality of life", 
                "safety_issue": "No", 
                "time_frame": "(0), Week 5, Week 9 (termination) and 2 months later (follow up)"
            }
        ], 
        "source": "University of Saskatchewan", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Dania Alrefai", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Dr.Jennifer Jones", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Dr.Hani Jawa", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Dr.Wael El-matary", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Saudi Arabian Cultural Bureau", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Saskatchewan", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}